Now, despite playing no formal role in the battle between Pfizer and Starboard, Guggenheim has found itself in the crossfire of one of the messiest activist campaigns in recent Wall Street memory.

Pfizer Inc. and Albert Bourla got the upper hand in an early skirmish against Starboard Value LP — but the drugmaker and its ...

Some misleading narratives about Bourla’s leadership that have been put forward have been distinctly unfair,' write Jeff ...

Pfizer is facing a messy showdown this week after an outside bid to revive the company’s post-Covid share plunge took an ...

In another twist to the tale of Starboard Value's push for change at Pfizer, the activist investor has claimed former ...